Tirzepatide and Retatrutide sit in metabolic and incretin receptor pathway research
Science (2022) 375(6582):eabm4459
Tesamorelin: Induces broad fat loss, particularly visceral fat, but via elevated HGH/IGF-1, which can bring both metabolic benefits and hormone-related risks Safety Profile AOD-9604: Well tolerated, with no significant effect on blood sugar or IGF-1 levels, making it appealing for long-term metabolic use
Main methods Assessment included magnesium sulfate (560 mg/kg intraperitoneally)-induced muscle weakness, muscle and brain lesions, hypermagnesemia, hyperkalaemia, increased serum enzyme values assessed in rats during and at the end of a 30-min period and medication (given intraperitoneally/kg at 15 min before magnesium) [BPC 157 (10 g, 10 ng), l-NAME (5 mg), l-arginine (100 mg), alone and/or together]
(2001) compared CSF non-protein-bound iron in 20 premature infants with ventricular hemorrhage and 10 normal premature infants and found that 75% of intraventricular hemorrhage (IVH) infants had CSF non-protein-bound iron, but none of the infants in the control group had CSF non-protein-bound iron, and all children with CSF non-protein-bound iron suffered white matter damage and subsequent disability
Zald, D
